Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases

被引:108
|
作者
Scalone, Luciana [1 ,2 ,3 ]
Ciampichini, Roberta [2 ]
Fagiuoli, Stefano [4 ]
Gardini, Ivan [5 ]
Fusco, Francesco [2 ]
Gaeta, Laura [4 ]
Del Prete, Anna [4 ]
Cesana, Giancarlo [1 ]
Mantovani, Lorenzo G. [2 ,6 ]
机构
[1] Univ Milano Bicocca, Res Ctr Publ Hlth, CESP, Milan, Italy
[2] CHARTA Fdn, Milan, Italy
[3] Fdn Charta, I-20122 Milan, Italy
[4] Osped Riuniti Bergamo, I-24100 Bergamo, Italy
[5] Patients Org EpaC ONLUS, Milan, Italy
[6] Univ Naples Federico II, Ctr Pharmacoecon, CIRFF, Naples, Italy
关键词
Health-related quality of life (HRQoL); Chronic hepatic diseases; EQ-5D-3L; EQ-5D-5L; Psychometric performance; QUALITY-OF-LIFE; LIVER-DISEASE; SPANISH VERSION; 5-LEVEL VERSION; 3-LEVEL SYSTEM; CANDIDATES; UTILITIES; VALIDITY;
D O I
10.1007/s11136-012-0318-0
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
To assess the performance of the EQ-5D-5L version compared with the standard EQ-5D-3L in a clinical setting targeted at patients with chronic hepatic diseases (CHDs). We introduced the 5L descriptive system into a cost-of-illness study involving patients with different CHDs. The patients completed a questionnaire including the two versions of the EQ-5D, together with other questions related to their condition. We tested the feasibility, the level of inconsistency, the redistribution properties among consistent responses, the ceiling effect, the discriminative power, and the convergent validity of the 5L compared with the 3L system. A total of 1,088 valid patients were recruited: 62 % male, 19-89 (median = 59) years old. Patients had chronic hepatitis from HCV (31.8 %) or HBV infections (29.3 %) or other causes (7.8 %), 20.4 % had cirrhosis, 11.9 % underwent liver transplantation, and 7.8 % had hepatic carcinoma. Less than 1 % of EQ-5D-5L were returned blank, and 1.6 % or less of missing values were calculated on the dimensions of the partially completed questionnaires. The proportion and weight of inconsistent responses (i.e., 3L responses that were at least two levels away from the 5L responses) was 2.9 % and 1.2 on average, respectively. Regarding redistribution, 57-65 % of the patients answering level 2 with the 3L version redistributed their responses to levels 2 or 4 with the 5L version. A relative 7 % reduction of the ceiling effect was found. Furthermore, the absolute informativity increased but the relative informativity slightly decreased in every domain, and the convergent validity with the VAS improved. In a clinical setting involving CHD patients, the EQ-5D-5L was shown to be feasible and with promising levels of performance. Our findings suggest that the 5L performs better in at least some of the properties analyzed, and encourage further research to also test other psychometric properties of this new version of the EQ-5D.
引用
收藏
页码:1707 / 1716
页数:10
相关论文
共 50 条
  • [21] Comparing measurement properties of EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients
    Fitriana, Titi Sahidah
    Purba, Fredrick Dermawan
    Rahmatika, Rina
    Muhaimin, Riski
    Sari, Nur Melani
    Bonsel, Gouke
    Stolk, Elly
    Busschbach, Jan J., V
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2021, 19 (01)
  • [22] Validation of the EQ-5D in Patients with Traumatic Limb Injury
    Hung, Mei-Chuan
    Lu, Wen-Shian
    Chen, Sheng-Shiung
    Hou, Wen-Hsuan
    Hsieh, Ching-Lin
    Wang, Jung-Der
    JOURNAL OF OCCUPATIONAL REHABILITATION, 2015, 25 (02) : 387 - 393
  • [23] Validity and reliability of the EQ-5D for cancer patients in Korea
    Kim, Seon Ha
    Hwang, Jung Sung
    Kim, Tae Won
    Hong, Yong Sang
    Jo, Min-Woo
    SUPPORTIVE CARE IN CANCER, 2012, 20 (12) : 3155 - 3160
  • [24] Responsiveness of the EQ-5D in patients with proximal humeral fractures
    Olerud, Per
    Tidermark, Jan
    Ponzer, Sari
    Ahrengart, Leif
    Bergstrom, Gunnar
    JOURNAL OF SHOULDER AND ELBOW SURGERY, 2011, 20 (08) : 1200 - 1206
  • [25] Proxy completion of EQ-5D in patients with dementia
    Bryan, S
    Hardyman, W
    Bentham, P
    Buckley, A
    Laight, A
    QUALITY OF LIFE RESEARCH, 2005, 14 (01) : 107 - 118
  • [26] Proxy completion of EQ-5D in patients with dementia
    S. Bryan
    W. Hardyman
    P. Bentham
    A. Buckley
    A. Laight
    Quality of Life Research, 2005, 14 : 107 - 118
  • [27] Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets
    van Hout, Ben
    Janssen, M. F.
    Feng, You-Shan
    Kohlmann, Thomas
    Busschbach, Jan
    Golicki, Dominik
    Lloyd, Andrew
    Scalone, Luciana
    Kind, Paul
    Pickard, A. Simon
    VALUE IN HEALTH, 2012, 15 (05) : 708 - 715
  • [28] Validation of EQ-5D in patients with cervical cancer in Taiwan
    Lang, Hui-Chu
    Chuang, Linghsiang
    Shun, Shiow-Ching
    Hsieh, Ching-Lin
    Lan, Chung-Fu
    SUPPORTIVE CARE IN CANCER, 2010, 18 (10) : 1279 - 1286
  • [29] The EQ-5D: A New Tool for Studying Clinical Outcomes in Chronic Rhinosinusitis
    Remenschneider, Aaron K.
    D'Amico, Laura
    Gray, Stacey T.
    Holbrook, Eric H.
    Gliklich, Richard E.
    Metson, Ralph
    LARYNGOSCOPE, 2015, 125 (01) : 7 - 15
  • [30] Danish EQ-5D population norms
    Sorensen, Jan
    Davidsen, Michael
    Gudex, Claire
    Pedersen, Kjeld Moller
    Bronnum-Hansen, Henrik
    SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2009, 37 (05) : 467 - 474